UTHR United Therapeutics
- 236.930
- +1.620+0.69%
United Therapeutics News
United Therapeutics(UTHR.US) Officer Sells US$1.68 Million in Common Stock
$United Therapeutics(UTHR.US)$ Officer ROTHBLATT MARTINE A sold 7,200 shares of common stock on Apr 15, 16, 2024 at an average price of $233.7248 for a total value of $1.68 million.Source: Announcemen
United Therapeutics Insider Sold Shares Worth $1,682,819, According to a Recent SEC Filing
Martine A Rothblatt, Director, Chairperson & CEO, on April 15, 2024, sold 7,200 shares in United Therapeutics (UTHR) for $1,682,819. Following the Form 4 filing with the SEC, Rothblatt has control ove
The Market Doesn't Like What It Sees From United Therapeutics Corporation's (NASDAQ:UTHR) Earnings Yet
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 17x, you may consider United Therapeutics Corporation (NASDAQ:UTHR) as an attractive investment w
United Therapeutics to Feature Clinical Data Across Its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference
Initial, interim long-term data from the ongoing ralinepag phase 3 ADVANCE EXTENSION open label study to be presented at a poster discussion sessionAn annual update of the preliminary baseline data fr
United Therapeutics(UTHR.US) Officer Sells US$1.71 Million in Common Stock
$United Therapeutics(UTHR.US)$ Officer ROTHBLATT MARTINE A sold 7,200 shares of common stock on Apr 11, 12, 2024 at an average price of $237.191 for a total value of $1.71 million.Source: Announcement
United Therapeutics Insider Sold Shares Worth $1,707,775, According to a Recent SEC Filing
Martine A Rothblatt, Director, Chairperson & CEO, on April 11, 2024, sold 7,200 shares in United Therapeutics (UTHR) for $1,707,775. Following the Form 4 filing with the SEC, Rothblatt has control ove
United Therapeutics(UTHR.US) Officer Sells US$6.83 Million in Common Stock
$United Therapeutics(UTHR.US)$ Officer ROTHBLATT MARTINE A sold 28,800 shares of common stock on Apr 9, 10, 2024 at an average price of $237.2131 for a total value of $6.83 million.Source: Announcemen
United Therapeutics Insider Sold Shares Worth $6,831,737, According to a Recent SEC Filing
Martine A Rothblatt, Director, Chairperson & CEO, on April 09, 2024, sold 28,800 shares in United Therapeutics (UTHR) for $6,831,737. Following the Form 4 filing with the SEC, Rothblatt has control ov
United Therapeutics(UTHR.US) Officer Sells US$4.73 Million in Common Stock
$United Therapeutics(UTHR.US)$ Officer ROTHBLATT MARTINE A sold 20,060 shares of common stock on Apr 5, 8, 2024 at an average price of $235.6797 for a total value of $4.73 million.Source: Announcement
S&P 500 Futures Up In Premarket Trading; Halozyme Therapeutics, Revvity Lead
This article was automatically generated by Barrons.com using technology from Automated Insights. With U.S. stock markets set to open in two hours, Halozyme Therapeutics Inc. (HALO) was up 7.7% in pr
Insider Sell: Chairperson & CEO Martine Rothblatt Sells 30,000 Shares of United ...
United Therapeutics Insider Sold Shares Worth $6,957,709, According to a Recent SEC Filing
Martine A Rothblatt, Director, Chairperson & CEO, on April 03, 2024, sold 30,000 shares in United Therapeutics (UTHR) for $6,957,709. Following the Form 4 filing with the SEC, Rothblatt has control ov
Insider Sell: EVP & GENERAL COUNSEL Paul Mahon Sells 6,000 Shares of United Therapeutics ...
United Therapeutics(UTHR.US) Officer Sells US$1.39 Million in Common Stock
$United Therapeutics(UTHR.US)$ Officer MAHON PAUL A sold 6,000 shares of Common Stock on Apr 4, 2024 at an average price of $232.3747 for a total value of $1.39 million.Source: Announcement What is st
United Therapeutics Insider Sold Shares Worth $1,394,248, According to a Recent SEC Filing
Paul A Mahon, Executive Vice President & General Counsel, on April 04, 2024, sold 6,000 shares in United Therapeutics (UTHR) for $1,394,248. Following the Form 4 filing with the SEC, Mahon has control
Form 144 | United Therapeutics(UTHR.US) Officer Proposes to Sell 1.39 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 4, $United Therapeutics(UTHR.US)$ Officer PAUL MAHON intends to sell 6,000 shares of its common stock on Apr 4, with a total market value of approximately $1.39 million.
United Therapeutics(UTHR.US) Officer Sells US$6.86 Million in Common Stock
$United Therapeutics(UTHR.US)$ Officer ROTHBLATT MARTINE A sold 30,000 shares of Common Stock on Apr 1, 2, 2024 at an average price of $228.6942 for a total value of $6.86 million.Source: Announcement
S&P 500 Futures Drop In Premarket Trading; PVH Corp., Humana Lag
This article was automatically generated by Barrons.com using technology from Automated Insights. With U.S. stock markets set to open in two hours, Roivant Sciences Ltd. (ROIV) was up 5.1% in pre-mar
Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension
Liquidia (LQDA) said Monday that a US court has set aside an injunction that had prohibited the US Food and Drug Administration from issuing final approval of Liquidia's amended new drug application f
United Therapeutics Motion for Restraining Order Over Liquidia's Yutrepia Denied
Analysis
Price Target
No Data
